Gene expression patterns of insulin-like growth factor 1, insulin-like growth factor 2 and insulin-like growth factor binding protein 3 in human placenta from pregnancies with intrauterine growth restriction

Journal of Perinatal Medicine

Volumn 39, Issue 6, 2011, Pages 701-707

  Börzsönyi, Balázs ^a   Demendi, Csaba ^a   Nagy, Zsolt ^b   Tóth, Katalin ^b   Csanád, Mónika ^b   Pajor, Attila ^a   Rigó Jr , János ^a   Joó, József Gábor ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NAGY GIN Diagnostics and Research Ltd   (Hungary)

Author keywords

Gene expression; glucose; insulin; insulin like growth factor; intrauterine growth restriction; placenta

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BIRTH WEIGHT; BODY MASS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MALE; MATERNAL NUTRITION; NEWBORN; PLACENTA; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; WEIGHT GAIN;

ADOLESCENT; ADULT; BASE SEQUENCE; BIRTH WEIGHT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; FETAL BLOOD; FETAL GROWTH RETARDATION; GENE EXPRESSION; HUMANS; INFANT, NEWBORN; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MATERNAL AGE; PLACENTA; PREGNANCY; RISK FACTORS; SEX RATIO; YOUNG ADULT;

EID: 80955140328     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2011.090     Document Type: Article

References (40)

1. Ashton IK, Zapf J, Einschenk I, MacKenzie IZ. Insulin-like growth factors (IGF) I and II in human fetal plasma and relationship to gestational age and fetal size during midpregnancy. Acta Endocrinol (Copenh). 1985;110:558-63.
2. Bartha JL, Comino-Delgado R. Lymphocyte subpopulations in intrauterine growth retardation in women with or without previous pregnancies. Eur J Obstet Gynecol Reprod Biol. 1999;82:23-7.
3. Constancia M, Hemberger M, Hughes J, Dean W, Ferguson- Smith A, Fundele R, et al. Placental-specific IGF-2 is a major modulator of placental and fetal growth. Nature. 2002;417: 945-8.
4. Cunningham FG, Leveno KJ. Childbearing among older women - the message is cautiously optimistic. N Engl J Med. 1995;333:1002-4.
5. De Zegher F, Francois I, van Helvoirt M, van den Berghe G. Clinical review 89: small as fetus and short as child: from endogenous to exogenous growth hormone. J Clin Endocrinol Metabol. 1997;82:2021-6.
6. Economides DL, Nicolaides KH. Blood glucose and oxygen tension levels in small-for-gestational-age fetuses. Am J ObstetGynecol. 1989;160:385-9.
7. Economides DL, Proudler A, Nicolaides KH. Plasma insulinin appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol. 1989;160:1091-4.
8. Fowden AL. Endocrine regulation of fetal growth. Reprod Fertil Develop. 1995;7:351-63.
9. Fowden AL. The insulin-like growth factors and feto-placental growth. Placenta. 2003;24:803-12.
10. Fraser AM, Brockert JE, Ward RH. Association of young maternal age with adverse reproductive outcomes. N Engl J Med. 1995;332:1113-7.
11. Giudice LC, de Zegher F, Gargosky SE, Dsupin BA, de las Fuentes L, Crystal RA, et al. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metabol. 1995;80:1548-55.
12. Gluckman PD, Harding JE. The physiology and pathophysiology of intrauterine growth retardation. Horm Res. 1997;48 (Suppl 1):11-6.
13. Gluckman PD, Grumbach MM, Kaplan SL. The neuroendocrine regulation and function of growth hormone and prolactin in mammalian fetus. Endo Rev. 1981;2:363-95.
14. Hales CN, Barker DJ. The thrifty phenotype hypothesis. Br Med Bull. 2001;60:5-20.
15. Hytten FE, Thomson AM. Maternal physiological adjustments. In: Assali NS, editors. Biology of gestation, Vol. I. The maternal organism. New York: Academic Press; 1968.
16. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endo Rev. 1995;16:3-34.
17. Kajimura S, Aida K, Duan C. Insulin-like growth factorbinding protein-1 (IGFBP-1) mediates hypoxia-induced embryonic growth and developmental retardation. Proc Natl Acad Sci USA. 2005;102:1240-5.
18. Kubota T, Kamada S, Taguchi M, Aso T. Determination of insulin-like growth factor-2 in feto-maternal circulation during human pregnancy. Acta Endocrinol. 1992;127:359-65.
19. Kuo PL. Glucose gradients of maternal vein-umbilical artery in normally grown and growth-retarded fetuses. J Perinat Med. 1991;19:421-5.
20. Lee JJ. Birth weight for gestational age patterns by sex, plurality and parity in Korean populations. Korean J Perinatol. 2007;18:1-11.
21. Lee MH, Jeon YJ, Lee MS, Park MH, Jung SC, Kim YJ. Placental gene expression is related to glucose metabolism and fetal cord blood levels of insulin and insulin-like growth factors in intrauterine growth restriction. Early Hum Dev. 2010;86:45-50.
22. Magnusson AL, Powell T, Wennergren M, Jansson T. Glucosemetabolism in the human preterm and term placenta of IUGR fetuses. Placenta. 2004;25:337-46.
23. Marconi AM, Cetin I, Davoli E, Baggiani AM, Fanelli R, Fennessey PV, et al. An evaluation of fetal glucogenesis in intrauterine growth-retarded pregnancies. Metabolism. 1993;42:860-4.
24. Meio MDB, Moreira MEL, Sichieri R, Moura AS. Reduction of IGF-binding protein-3 as a potential marker of intrauterine growth restriction. J Perinat Med. 2009;37:689-93.
25. Lee MH, Jeon YJ, Lee SM, Park MH, Jung SC, Kim YJ. Placental gene expression is related to glucose metabolism and fetal cord blood levels of insulin and insulin-like growth factors in intrauterine growth restriction. Early Hum Develop. 2010;86:45-50.
26. Murisier-Petetin G, Gremlich S, Damnon F, Reymondin D, Hohlfeld P, Gerber S. Amniotic fluid insulin-like growth factor binding protein 3 concentration as early indicator of fetal growth restriction. Eur J Obstet Gynecol Reprod Biol. 2009; 144:15-20.
27. Nagy Zs, Börzsöniy B, Demendi CS, et al. Gender specific gene expression of IGF-1 and IGF-2 in second trimester amniotic fluid cells. Obstet Gynecol. 2011 (under review).
28. Neitzke U, Harder T, Plagemann A. Intrauterine growth restriction and developmental programming of the metabolic syndrome: a critical appraisal. Microcirculation. 2011;18: 304-11.
29. Ozanne SE, Hales N. Early programming of glucose-insulin metabolism. Trends Endocrin Metabol. 2002;13:368-73.
30. Pahlman S, Meyerson G, Lindgren E, Schalling M, Johansson I. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation. Proc Natl Acad Sci USA. 1991;88:9994-8.
31. Plagemann A. A matter of insulin: developmental programming of body weight regulation. J Maternal Fetal Neonatal Med. 2008;21:143-8.
32. Samaan NA, Schultz PN, Johnston DA, Creasy RW, Gonik B. Growth hormone, somatomedin C, and non-suppressible insulin-like activity levels compared in premature, small,average birth weight, and large infants. Am J Obstet Gynecol. 1987;157:1524-8.
33. Sheikh S, Satoskar P, Bhartiya D. Expression of insulin-likegrowth factor-I and placental growth hormone mRNA in placentae:a comparison between normal and intrauterine growthretardation pregnancies. Mol Hum Reprod. 2001;7:287-92.
34. Street ME, Seghini P, Fieni S, Ziveri MA, Volta C, Martorana D, et al. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol. 2006;155:567-74.
35. Tisi DK, Liu XJ, Wykes LJ, Skinner CD, Koski KG, et al.Insulin-like growth factor II and binding proteins 1 and 3 from second trimester human amniotic fluid are associated with infant birth weight. J Nutr. 2005;135:1667-72.
36. Van Assche FA, Holemans K, Aerts L. Fetal growth and consequences for later life. J Perinat Med. 1998;26:337-46.
37. Varner MW. Disproportionate fetal growth. In: DeCherney AH, Pernoll ML, editors. Current obstetric & gynaecologic diagnosis & treatment. East Norwalk: Appleton & Lange; 1994. pp. 344-56.
38. Wang HS, Lim J, English J, Irvine L, Chard T. The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J Endocrinol. 1991;129: 459-64.
39. Wang HS, Chard T. The role of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in the control of human fetal growth. J Endocrinol. 1992;132:11-9.
40. Wollmann HA. Intrauterine growth restriction: definition and etiology. Horm Res. 1988;49(Suppl 2):1-6.